Biomarkers of An Autoimmune Skin Disease--Psoriasis

Overview

Journal Genomics Proteomics Bioinformatics

Specialty Biology

Date 2015 Sep 13

PMID 26362816

Citations 46

Authors

Shan Jiang

Taylor E Hinchliffe

Tianfu Wu

Affiliations

Soon will be listed here.

Abstract

Psoriasis is one of the most prevalent autoimmune skin diseases. However, its etiology and pathogenesis are still unclear. Over the last decade, omics-based technologies have been extensively utilized for biomarker discovery. As a result, some promising markers for psoriasis have been identified at the genome, transcriptome, proteome, and metabolome level. These discoveries have provided new insights into the underlying molecular mechanisms and signaling pathways in psoriasis pathogenesis. More importantly, some of these markers may prove useful in the diagnosis of psoriasis and in the prediction of disease progression once they have been validated. In this review, we summarize the most recent findings in psoriasis biomarker discovery. In addition, we will discuss several emerging technologies and their potential for novel biomarker discovery and diagnostics for psoriasis.

Citing Articles

Anti-Inflammatory Effects of Curcumin-Based Nanoparticles Containing α-Linolenic Acid in a Model of Psoriasis In Vitro.

Serini S, Trombino S, Cassano R, Marino M, Calviello G Nutrients. 2025; 17(4).

PMID: 40005020 PMC: 11858589. DOI: 10.3390/nu17040692.

Identification and mechanistic insights of cell senescence-related genes in psoriasis.

Deng G, Xu C, Mo D PeerJ. 2025; 13():e18818.

PMID: 39830966 PMC: 11740738. DOI: 10.7717/peerj.18818.

Systematic analysis of serum peptidase inhibitor 3 in psoriasis diagnosis and treatment.

Xu M, Deng H, Zhang X, Deng J, Yu W, Han L Clin Rheumatol. 2024; 43(11):3361-3372.

PMID: 39287701 DOI: 10.1007/s10067-024-07138-5.

Loss-of-function mutations in Keratin 32 gene disrupt skin immune homeostasis in pityriasis rubra pilaris.

Shi P, Chen W, Lyu X, Wang Z, Li W, Jia F Nat Commun. 2024; 15(1):6259.

PMID: 39048559 PMC: 11269665. DOI: 10.1038/s41467-024-50481-z.

Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis.

Zhou Y, Ding Y, Cui M, Zhang Y, Wang M, Zhou F Med Sci Monit. 2024; 30:e943360.

PMID: 38715343 PMC: 11089906. DOI: 10.12659/MSM.943360.

References

Piruzian E, Bruskin S, Ishkin A, Abdeev R, Moshkovskii S, Melnik S . Integrated network analysis of transcriptomic and proteomic data in psoriasis. BMC Syst Biol. 2010; 4:41. PMC: 2873316. DOI: 10.1186/1752-0509-4-41. View

Sitter B, Johnsson M, Halgunset J, Bathen T . Metabolic changes in psoriatic skin under topical corticosteroid treatment. BMC Dermatol. 2013; 13:8. PMC: 3751591. DOI: 10.1186/1471-5945-13-8. View

Oestreicher J, Walters I, Kikuchi T, Gilleaudeau P, Surette J, Schwertschlag U . Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J. 2002; 1(4):272-87. DOI: 10.1038/sj.tpj.6500067. View

Carlen L, Sanchez F, Bergman A, Becker S, Hirschberg D, Franzen B . Proteome analysis of skin distinguishes acute guttate from chronic plaque psoriasis. J Invest Dermatol. 2005; 124(1):63-9. DOI: 10.1111/j.0022-202X.2004.23501.x. View

Kocak M, Bozdogan O, Erkek E, Atasoy P, Birol A . Examination of Bcl-2, Bcl-X and bax protein expression in psoriasis. Int J Dermatol. 2003; 42(10):789-93. DOI: 10.1046/j.1365-4362.2003.01821.x. View

Garbaraviciene J, Diehl S, Varwig D, Bylaite M, Ackermann H, Ludwig R . Platelet P-selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasis. Exp Dermatol. 2010; 19(8):736-41. DOI: 10.1111/j.1600-0625.2010.01095.x. View

Nair R, Stuart P, Henseler T, Jenisch S, Chia N, Westphal E . Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet. 2000; 66(6):1833-44. PMC: 1378062. DOI: 10.1086/302932. View

Lundberg K, Fritz Y, Johnston A, Foster A, Baliwag J, Gudjonsson J . Proteomics of skin proteins in psoriasis: from discovery and verification in a mouse model to confirmation in humans. Mol Cell Proteomics. 2014; 14(1):109-19. PMC: 4288247. DOI: 10.1074/mcp.M114.042242. View

Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang Y, Homey B . Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007; 449(7162):564-9. DOI: 10.1038/nature06116. View

10.

Armstrong A, Wu J, Johnson M, Grapov D, Azizi B, Dhillon J . Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis. F1000Res. 2015; 3:248. PMC: 4288418. DOI: 10.12688/f1000research.4709.1. View

11.

Nestle F, Kaplan D, Barker J . Psoriasis. N Engl J Med. 2009; 361(5):496-509. DOI: 10.1056/NEJMra0804595. View

12.

Cao J . The functional role of long non-coding RNAs and epigenetics. Biol Proced Online. 2014; 16:11. PMC: 4177375. DOI: 10.1186/1480-9222-16-11. View

13.

Wu T, Xie C, Bhaskarabhatla M, Yan M, Leone A, Chen S . Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum. 2007; 56(3):949-59. DOI: 10.1002/art.22556. View

14.

Gaffen S, Jain R, Garg A, Cua D . The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014; 14(9):585-600. PMC: 4281037. DOI: 10.1038/nri3707. View

15.

Gerkowicz A, Pietrzak A, Szepietowski J, Radej S, Chodorowska G . Biochemical markers of psoriasis as a metabolic disease. Folia Histochem Cytobiol. 2012; 50(2):155-70. DOI: 10.5603/fhc.2012.0025. View

16.

Tsoi L, Iyer M, Stuart P, Swindell W, Gudjonsson J, Tejasvi T . Analysis of long non-coding RNAs highlights tissue-specific expression patterns and epigenetic profiles in normal and psoriatic skin. Genome Biol. 2015; 16:24. PMC: 4311508. DOI: 10.1186/s13059-014-0570-4. View

17.

Gold L, Walker J, Wilcox S, Williams S . Advances in human proteomics at high scale with the SOMAscan proteomics platform. N Biotechnol. 2011; 29(5):543-9. DOI: 10.1016/j.nbt.2011.11.016. View

18.

Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A . Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007; 157(1):68-73. DOI: 10.1111/j.1365-2133.2007.07986.x. View

19.

Tsoi L, Spain S, Knight J, Ellinghaus E, Stuart P, Capon F . Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet. 2012; 44(12):1341-8. PMC: 3510312. DOI: 10.1038/ng.2467. View

20.

Zhang X, Huang W, Yang S, Sun L, Zhang F, Zhu Q . Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet. 2009; 41(2):205-10. DOI: 10.1038/ng.310. View